AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 287: R354-R359, 2004. First published April 29, 2004; doi:10.1152/ajpregu.00705.2003
0363-6119/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/2/R354    most recent
00705.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glatzle, J.
Right arrow Articles by Raybould, H. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glatzle, J.
Right arrow Articles by Raybould, H. E.

APPETITE, OBESITY AND METABOLISM

Apolipoprotein A-IV stimulates duodenal vagal afferent activity to inhibit gastric motility via a CCK1 pathway

J. Glatzle,1,2 N. Darcel,1 A. J. Rechs,1,3 T. J. Kalogeris,4 P. Tso,5 and H. E. Raybould1

1Department of Anatomy, Physiology, and Cell Biology, School of Veterinary Medicine, University of California, Davis 95616; 3Department of Biology, California State University Sacramento, Sacramento, California 95819; 2University Hospital, Department of General Surgery, University of Tübingen, 72074 Tübingen, Germany; 4Department of Surgery, Louisiana University School of Medicine, Shreveport, Louisiana 71130; and 5Department of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, Ohio 45267

Submitted 9 December 2003 ; accepted in final form 13 April 2004

Apolipoprotein A-IV (apo A-IV), a peptide expressed by enterocytes in the mammalian small intestine and released in response to long-chain triglyceride absorption, may be involved in the regulation of gastric acid secretion and gastric motility. The specific aim of the present study was to determine the pathway involved in mediating inhibition of gastric motility produced by apo A-IV. Gastric motility was measured manometrically in response to injections of either recombinant purified apo A-IV (200 µg) or apo A-I, the structurally similar intestinal apolipoprotein not regulated by triglyceride absorption, close to the upper gastrointestinal tract in urethane-anesthetized rats. Injection of apo A-IV significantly inhibited gastric motility compared with apo A-I or vehicle injections. The response to exogenous apo A-IV injections was significantly reduced by 77 and 55%, respectively, in rats treated with the CCK1 receptor blocker devazepide or after functional vagal deafferentation by perineural capsaicin treatment. In electrophysiological experiments, isolated proximal duodenal vagal afferent fibers were recorded in vitro in response to close-arterial injection of vehicle, apo A-IV (200 µg), or CCK (10 pmol). Apo A-IV stimulated the discharge of duodenal vagal afferent fibers, significantly increasing the discharge in 4/7 CCK-responsive units, and the response was abolished by CCK1 receptor blockade with devazepide. These data suggest that apo A-IV released from the intestinal mucosa during lipid absorption stimulates the release of endogenous CCK that activates CCK1 receptors on vagal afferent nerve terminals initiating feedback inhibition of gastric motility.

lipid; chylomicrons; mesenteric lymph; cholecytokinin



Address for reprint requests and other correspondence: H. Raybould, VET MED: APC, 1321 Haring Hall, Univ. of California, Davis, CA 95616 (E-mail: heraybould{at}ucdavis.edu).




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. M. Lo, D. M. Zhang, K. Pearson, L. Ma, W. Sun, R. R. Sakai, W. S. Davidson, M. Liu, H. E. Raybould, S. C. Woods, et al.
Interaction of apolipoprotein AIV with cholecystokinin on the control of food intake
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1490 - R1494.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. Tome
From gut nutrient sensing to nutrient perception: a cooperative role involving CCK and 5-HT?
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1061 - R1062.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. Dufresne, C. Seva, and D. Fourmy
Cholecystokinin and gastrin receptors.
Physiol Rev, July 1, 2006; 86(3): 805 - 847.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. L. Whited, D. Lu, P. Tso, K. C. Kent Lloyd, and H. E. Raybould
Apolipoprotein A-IV is involved in detection of lipid in the rat intestine
J. Physiol., December 15, 2005; 569(3): 949 - 958.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.